A novel antiproliferative factor and methods of use

Details for Australian Patent Application No. 2004264853 (hide)

International Classifications

Event Publications

25 May 2006 Section 223 Application Allowed

University of Maryland Baltimore; Government of the United States of America as represented by The Secretary of the Department of Health and Human Services The time in which to enter the National Phase has been extended to 15 Mar 2006. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Melbourne VIC 3000

1 June 2006 PCT application entered the National Phase

PCT publication WO2005/016248 Priority application(s): WO2005/016248

27 October 2011 Application Accepted

Published as AU-B-2004264853

22 December 2011 Amendment Made

The nature of the amendment is: Amend the name of the inventor to read Conrads, Thomas P.; Veenstra, Timothy D. 2005

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.